No pharmacokinetic interactions between candesartan and amlodipine following multiple oral administrations in healthy subjects

by Kim JR, Kim S, Huh W, Ko JW
Published 2018-08-01

Effects of amoxicillin/clavulanic acid on the pharmacokinetics of valproic acid

by Lee SY, Huh W, Jung JA, Yoo HM, Ko JW, Kim JR
Published 2015-08-01

Bioequivalence evaluation of two amlodipine salts, besylate and orotate, each in a fixed-dose combination with olmesartan in healthy subjects

by Lee SY, Kim JR, Jung JA, Huh W, Bahng MY, Ko JW
Published 2015-06-01

Lack of the effect of lobeglitazone, a peroxisome proliferator-activated receptor-γ agonist, on the pharmacokinetics and pharmacodynamics of warfarin

by Jung JA, Lee SY, Kim TE, Kim JR, Kim C, Huh W, Ko JW
Published 2015-03-01

A pharmacokinetic and pharmacodynamic drug interaction between rosuvastatin and valsartan in healthy subjects

by Jung JA, Lee SY, Kim JR, Ko JW, Jang SB, Nam SY, Huh W
Published 2015-03-01

Exposure–outcome analysis in depressed patients treated with paroxetine using population pharmacokinetics

by Kim JR, Woo HI, Chun MR, Lim SW, Kim HD, Na HS, Chung MW, Myung W, Lee SY, Kim DK
Published 2015-09-01

Opioid Epidemic in the United States: Empirical Trends, and A Literature Review of Social Determinants and Epidemiological, Pain Management, and Treatment Patterns

by Gopal K Singh, PhD, MS, MSc, Isaac E. Kim, Jr., BSc, Mehrete Girmay, PhD, MPH, CGH, Chrisp Perry, MPH, Gem P. Daus, MA, Ivy P. Vedamuthu, MPH, Andrew A. De Los Reyes, Christine T. Ramey, MBA, BSN, RN, Elijah K. Martin, Jr., EdD, MPH, Michelle Allender, MS, BSN, RN
Published 2019-09-01